Menu
Menu
Clinical Trials
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
TOI to attend the conference June 2-6 in Chicago CERRITOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) — The Oncology Institute (NASDAQ: TOI), one of the ...
Read More
The Oncology Institute Rebrands Clinical Trials Division
Innovative Clinical Research Institute Will Become TOI Clinical Research The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the ...
Read More
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
Value-based Oncology Leader Improving Access to Cutting-Edge Therapies CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — The Oncology Institute, Inc. (NASDAQ: TOI), today announces the ...
Read More
On the Path to Treating Myelofibrosis
Myelofibrosis (MF) is a rare condition that occurs in the bone marrow, disrupting the body’s normal production of red and white blood cells. This type of cancer, which causes scarring in the bone marrow, can develop on ...
Read More
Clinical Trials at ICRI: August Round-Up
Deciding to participate in a clinical trial is a personal decision that can potentially have a profound beneficial impact on a patient’s cancer journey. Although many patients may be interested in ...
Read More
Understanding Clinical Trials
Video: Tarek Dessouky, MD, MBA, MPH, Executive Director, Innovative Clinical Research Institute (ICRI) talks about the research arm of The Oncology Institute (TOI) and discusses ...
Read More
© 2022 The Oncology Institute of Hope and Innovation. All rights reserved.